Skip to main content
SpringerLink
Log in

CASE REPORT: Clostridium difficile Colitis in Children with Cystic Fibrosis

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. Rivlin J, Lerner A, Augarten A, Wilschanski M, Kerem E, Ephros MA:Severe Clostridium difficile-associated colitis in young patients with cystic fibrosis. J. Pediatr 132:177–179, 1998

    Google Scholar 

  2. Winesett DE, Rhoads JM, Boat TF: Pseudomembranous colitis in a patient with cystic fibrosis. J Pediatr Gastroenterol Nutr18:244–246, 1994

    Google Scholar 

  3. Hall IC, O'Toole E: Intestinal flora in newborn infants with a description of a new pathogenic anaerobe: Bacillus difficilis. Am J Dis Child 49:390–402, 1935

    Google Scholar 

  4. Klinger PJ, Metzger PP, Seelig MH, Pettit PD, Knudsen JM, Alvarez S: Clostridium difficile infection: Risk factors, medical and surgical management. Dig Dis 18:147–60, 2000

    Google Scholar 

  5. Kelly CP, LaMont JT: Clostridium difficile infection. Annu Rev 49:375–390, 1998

    Google Scholar 

  6. Mylonakis E, Ryan ET, Caldwerwood SB: Clostridium difficile-associated diarrhea. Arch Intern Med 161:525–531, 2001

    Google Scholar 

  7. Bartlett JG: Antibiotic associated diarrhea. Clin Infect Dis 15:573–581, 1992

    Google Scholar 

  8. Wu TC, McCarthyVP, Gill VP: Isolation rate and toxigenic potential of Clostridium difficile isolates from patients with cystic fibrosis. J Infect Dis 148:176, 1983

    Google Scholar 

  9. Tedesco FJ, Anderson CB, Ballinger WF: Drug-induced colitis mimicking an acute surgical condition of the abdomen. Arch Surg 110:481–484, 1975

    Google Scholar 

  10. Meyers S, Mayer L, Bottone E, Desmond E, Janowitz HD: Occurrence of Clostridium difficile toxin during the course of inflammatory bowel disease. Gastroenterology 80:697–700, 1981

    Google Scholar 

  11. Fainstein V, Bodey GP, Fekety R: Relapsing pseudomembranous colitis associated with cancer chemotherapy. J Infect Dis 143:865, 1981

    Google Scholar 

  12. Peach SL, Borriello SP, Gaya H, Barclay FE, Welch AR: Asymptomatic carriage of Clostridium difficile in patients with cystic fibrosis. J Clin Pathol 39:1013–1018, 1986

    Google Scholar 

  13. Peach SL, Borriello SP, Gaya H: Carriage of Clostridium difficile in patients with cystic fibrosis and control group. J Med Microbiol 18:5, 1984

    Google Scholar 

  14. Welkon CJ, Long SS, Thompson M Jr, Gilligan PH: Clostridium difficile in patients with cystic fibrosis. Am J Dis Child 139:805–808, 1985

    Google Scholar 

  15. Sherertz RJ, Sarubbi FA: The prevalence of Clostridium difficile and toxin in a nursery population: A comparison between patients with necrotizing enterocolitis and an asymptomatic group. J Pediatr 100:435–439, 1982

    Google Scholar 

  16. Pokorny CS, Bye PTP, Macleod C, Selby WS: Antibiotic-associated colitis and cystic fibrosis. Dig Dis Sci 37:1464–1468, 1992

    Google Scholar 

  17. Barbero GJ, Schwachman H, Grand R, et al.: Gastrointestinal and nutritional manifestations of cystic fibrosis. In Cystic Fibrosis: Projections into the Future. Mangos JA, Talamo RC (eds). Miami, Symposia Specialists, 1976, pp 83–111

  18. Rolfe RD, Helebian S, Finegold SM: Bacterial interference between Clostridium difficile and normal fecal flora. J Infect Dis 143:470–475, 1981

    Google Scholar 

  19. Wilson KH, Silva J, Fekety R: Suppression of Clostridium difficile by normal hamster cecal flora and prevention of antibiotic-associated cecitis. Infect Immun 34:626–628, 1981

    Google Scholar 

  20. Catagliuolo l, Valenick L, Riegler M, LaMont JT, Pothoulakis C: Oligosaccharide containing sialic acid and N-acetyl-glycosamine mediate Clostridium difficile toxin B(TxB) binding and biological effects in human colonic mucosa. Gastroenterology 114:A949(abstr G3889), 1998

    Google Scholar 

  21. Viscidi R, Laughon BE, Yolken R, Bo-Linn P, Moench T, Ryder RW, Bartlett JG: Serum antibody response to toxins A and B of Clostridium difficile. J Infect Dis 148:93–100, 1983

    Google Scholar 

  22. Aoronsson B, Granstrom M, Mollby R, Nord CE: Serum antibody response to Clostridium difficile toxins in patients with Clostridium difficile diarrhea. Infection 13:97–101, 1985

    Google Scholar 

  23. Warny M, Vaerman JP, Avesani V, Delmee M: Human antibody response to Clostridium difficile toxinAin relation to clinical course of infection. Infect lmmun 62:384–389, 1994

    Google Scholar 

  24. Kyne L, Warny M, Qamar A, Kelly CP: Asymptomatic carriage of Clostridium difficile and serum levels of lgG antibody against toxin A. N Engl J Med 342:390–397, 2000

    Google Scholar 

  25. Leung DY, Kelly CP, Boguniewicz M, Pothoulakis C, LaMont JT, Flores A: Treatment with intravenously administered gamma globulins of chronic relapsing colitis induced by Clostridium difficile toxin. J Pediatr 118:633–637, 1991

    Google Scholar 

  26. Dallal RM, Harbrecht BG, Boujoukas AJ, Sirio CA, Farkas LM, Lee KK, Simmons RL: Fulminant Clostridium difficile: an under-appreciated and increasing cause of death and complications. Ann Surg 235:363–372, 2002

    Google Scholar 

  27. Putterman C, Rubinow A: Reactive arthritis associated with Clostridium difficile associated pseudomembranous colitis. Semin Arthritis Rheum 22:420–426, 1993

    Google Scholar 

  28. Binkovitz LA, Allen E, Bloom D, Long F, Hammond S, Buonomo C, Donnelly LF: Atypical presentation of Clostridium difficile colitis in patients with cystic fibrosis. Am J Roentgenol 172:517–521, 1999

    Google Scholar 

  29. Fang FC, Madinger NE: Clostridium difficile colitis. N Engl J Med 330:1754, 1994

    Google Scholar 

  30. Talbot RW, Walker RC, Beart RW Jr.: Changing epidemiology, diagnosis and treatment of Clostridium difficile toxin-associated colitis. Br J Surg 73:457–460, 1986

    Google Scholar 

  31. Tedesco FJ, Corless JK, Brownstein RE: Rectal sparing in antibiotic-associated pseudomembranous colitis. A prospective study. Gastroenterology 77:295–297, 1979

    Google Scholar 

  32. Burbige EJ, Radigan JJ: Antibiotic associated colitis normal appearing rectum. Dis Colon Rectum 24:198–200, 1981

    Google Scholar 

  33. Pickhardt PJ, Yagan N, Siegel MJ, Balfe DM, Rothbaum RJ: Cystic fibrosis: CT findings of colonic disease. Radiology 206:725–730, 1998

    Google Scholar 

  34. Fishman EK, Kavuru M, Jones B: Pseudomembranous colitis: CT evaluation of 26 cases. Radiology 180:57–60, 1991

    Google Scholar 

  35. Merine D, Fishman EK, Jones B: Pseudomembranous colitis: CT evaluation. J Comput Assist Tomogr 11:1017–1020, 1987

    Google Scholar 

  36. Goodman PC, Federle MP: Pseudomembranous colitis. J Comput Assist Tomogr 4:403–404, 1980

    Google Scholar 

  37. Yankes JR, Baker MD, Cooper C, Garbutt J: CT appearance of focal pseudomembranous colitis. J Comput Assist Tomogr 12:394–396, 1988

    Google Scholar 

  38. Hamrick KM, Tishler JM, Schwartz ML, Koslin DB, Han SY: The CT findings in pseudomembranous colitis. Comput Med Imaging Graph 13:343–346, 1989

    Google Scholar 

  39. Schmitt-Grohe S, Wiggen E, Steffan J, Handke R, Zielen S: Severe antibiotic-associated colitis in a patient with cystic fibrosis and colonic wall thickening. J Pediatr Gastroenterol Nutr 34:224–226, 2002

    Google Scholar 

  40. Johnson S, Homann SR, Bettin KM, Quick JN, Clabots CR, Peterson LR, Gerding DN: Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole: a randomized, placebo-controlled study. Ann Intern Med 117:297–302, 1992

    Google Scholar 

  41. Teasley DG, Gerding DN, Olson MM, Peterson LR, Gebhard RL, Schwartz MJ, Lee JT Jr.: Prospective randomized trial of metronidazole versus vancomycin for Clostridium difficile-associated diarrhea and colitis. Lancet 2:1043–1046, 1983

    Google Scholar 

  42. Moyenuddin M, Williamson JC, Ohl CA: Clostridium difficile-associated diarrhea: Current strategies for diagnosis and therapy. Curr Gastroenterol Rep 4:279–286, 2002

    Google Scholar 

  43. Bartlett JG: Treatment of Clostridium difficile colitis. Gastroenterology 89:1192–1195, 1985

    Google Scholar 

  44. Saginur R, Hawley CR, Bartlett JG: Colitis associated with metronidazole therapy. J Infect Dis 141:772–774, 1980

    Google Scholar 

  45. Thomson G, Clark AH, Hare K, Spilg WGS: Pseudomembranous colitis after treatment with metronidazole. Br Med J 282:864–865, 1981

    Google Scholar 

  46. Guerrant RL, Gilder TV, Steiner TS, Thielman NM, Slutsker L, Tauxe RV, Hennessy T, Griffin PM, Du Pont H, Sack RB, Tarr P, Neill M, Nachamkin I, Reller LB, Osterholm MT, Bennish ML, Pickering LK: Infectious Diseases Society of America: Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 32:331–351, 2001

    Google Scholar 

  47. Kyne L, Kelly CP: Recurrent Clostridium difficile diarrhea. Gut 49:152–153, 2001

    Google Scholar 

  48. Pochapin M: The effect of probiotic on Clostridium difficile diarrhea. Am J Gastroenterol 95: S11–S13, 2000

    Google Scholar 

  49. Surawicz CM, Elmer GW, Speelman P, McFarland LV, Chinn J, van Belle G: Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: A prospective study. Gastroenterology 96:981–988, 1989

    Google Scholar 

  50. Gorbach SL, Chang TW, Goldin B: Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 2:1519, 1987

    Google Scholar 

  51. Rifkin GD, Fekety FR, Silva J Jr: Antibiotic-induced colitis implication of a toxin neutralized by Closiridium Sordelli Anti-Toxin. Lancet 11:1103–1106, 1977

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

    Sunny Zaheed Hussain & Seema Khan

  2. Department of Pediatrics and Medical Genetics, Cedars-Sinai Medical Center, UCLA, Los Angeles, California, USA

    Cathy Chu

  3. Division of Allergy, Immunology and Infectious Diseases, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

    David P. Greenberg

  4. Division of Pulmonology, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

    David Orenstein

Authors
  1. Sunny Zaheed Hussain
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cathy Chu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David P. Greenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David Orenstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Seema Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hussain, S.Z., Chu, C., Greenberg, D.P. et al. CASE REPORT: Clostridium difficile Colitis in Children with Cystic Fibrosis. Dig Dis Sci 49, 116–121 (2004). https://doi.org/10.1023/B:DDAS.0000011612.74033.78

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:DDAS.0000011612.74033.78

Search

Navigation